Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Spiolto/Respimat in CHF and COPD
NCT02812862Phase 4Withdrawn
- Sponsor
- RWTH Aachen University
- Start
- Aug 2016
- Primary completion
- Aug 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of tiotropium, olodaterol in chronic obstructive pulmonary disease (COPD), sponsored by RWTH Aachen University. Planned start Aug 2016; status: withdrawn.
02
Drugs
tiotropiumolodaterol
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT02812862.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02812862.